TITLE

MD BIOSCIENCES LAUNCHES NEUROLOGY DISCOVERY SERVICES

PUB. DATE
July 2006
SOURCE
Worldwide Biotech;Jul2006, Vol. 18 Issue 7, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the launch of Neurology Discovery Services, an expansion of the laboratory facility of MD Biosciences in Israel. Significance of the expanded laboratory to the company's growing service portfolio; Background on the operations of MD Biosciences; Products and pre-clinical services offered by MD Biosciences.
ACCESSION #
21352199

 

Related Articles

  • mdb iosciences.  // Contract Pharma;2010 Directory, Vol. 11 Issue 10, p144 

    The article profiles MD Biosciences Inc., a contract research organization for pharmaceutical industry located in St. Paul, Minnesota. The company's expertise is the development of drug for therapeutic areas that include inflammatory/autoimmune, neurological diseases and pain. Also, MD...

  • MD Biosciences, Inc.  // Contract Pharma;2012 Corporate Capabilities, Vol. 13 Issue 10, p122 

    The article profiles MD Biosciences Inc., a drug development and preclinical contract research organization based in St. Paul, Minnesota which was founded in 1992. It mentions several key officials of the company including chief executive officer Eddie Moradian, manager of operations Allen...

  • LABORATORY SERVICES.  // BioPharm International;Dec2011, Vol. 24 Issue 12, p55 

    The article offers information on the Lancaster Laboratories Inc., which global pharmaceutical and biotech services for the pharmaceutical and biopharmaceutical companies.

  • The right chemistry. Srivastava, Amitabh // India Today;12/ 8/2008, p40 

    The article features Samprada Singh, who at age 11 was part of a mob that set a police station on fire under British India and was considered by his fellow villagers at Jehanabad, Bihar as the person least likely to succeed. Samprada's big chance in the pharmaceutical industry came after he...

  • COMPANY SPOTLIGHT - Forest Laboratories.  // PharmaWatch: CNS;January 2005, Vol. 4 Issue 1, p18 

    Profiles Forest Laboratories Inc., a pharmaceutical company, in New York. Company operations; Financial performance; Products and services.

  • Charles River.  // Contract Pharma;2012 Corporate Capabilities, Vol. 13 Issue 10, p54 

    The article profiles Charles River, a global pharmaceutical providers in Wilmington, Massachusetts which was founded in 1947 and has 7,500 employees. It states that the company helps to improve accelerate drug discovery and provides high quality research models, process manufacturing and...

  • Letters. Morales, Katie; Kessler, James; Young, Danny A.; Ravert, W.; Lieberman, M.; Franklin, John; DeBus, Robert; Montalbano, Anthony // Drug Topics;Mar2011, Vol. 155 Issue 3, p13 

    Several letters to the editor are presented in response to articles in previous issues including "Evolving Pharmacy Practice in the 21st century" in the January 2011 issue, "When efficiency is all that matters," by Dennis Miller, and "Let's eliminate meth labs, not find more of them," by Kent...

  • Sun Pharma makes open offer for Zenotech.  // FRPT- Finance Snapshot;4/20/2014, p14 

    The article reports on the open offer made by pharmaceutical company Sun Pharmaceuticals Industries Ltd. to buy 28.1 per cent of small sized biotech company Zenotech Laboratories Ltd. The amount of the share to be bought is said to cost up to Rupees 18.41 crore. The deal is saids to have been...

  • THE SUPPLY SHELF.  // Modern Healthcare;01/22/2001, Vol. 31 Issue 4, p22 

    Presents news briefs on pharmaceutical industry in the United States as of January 22, 2001. Information on a study conducted by Tufts Center for the Study of Drug Development on drug costs; Outlook of Moody's Investors Services company for the industry in 2001; Formation of the National...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics